We are live on ! Find out more
GS

GTS Securities Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.76%
This Fund
S&P 500
This Quarter Est. Return
+13.73%
1 Year Est. Return
+21.76%
3 Year Est. Return
+68.93%
5 Year Est. Return
10 Year Est. Return
AUM
$58.7B
AUM Growth
+$3.07B
Cap. Flow
-$4.44B
Cap. Flow %
-7.56%
Top 10 Hldgs %
36.76%
Holding
4,579
New
695
Increased
1,693
Reduced
1,580
Closed
585

Sector Composition

Rank Sector Weight
1 Technology 1.49%
2 Consumer Discretionary 0.8%
3 Communication Services 0.64%
4 Healthcare 0.57%
5 Financials 0.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FYBR
3376
DELISTED
Frontier Communications
FYBR
$250K ﹤0.01%
9,875
-2,550
-21% -$51.5K
CADE
3377
DELISTED
Cadence Bank
CADE
$250K ﹤0.01%
+8,451
New +$206K
TXT icon
3378
PUT
Textron
TXT
$15.4B
$249K ﹤0.01%
+3,100
New +$240K
CRNX icon
3379
PUT
Crinetics Pharmaceuticals
CRNX
$8.92B
$249K ﹤0.01%
7,000
-38,200
-85% -$1.17M
IYC icon
3380
iShares US Consumer Discretionary ETF
IYC
$1.23B
$249K ﹤0.01%
+3,287
New +$229K
JMIA
3381
Jumia Technologies
JMIA
$767M
$248K ﹤0.01%
70,282
+29,123
+71% +$87.5K
EQX icon
3382
PUT
Equinox Gold
EQX
$13.5B
$248K ﹤0.01%
50,700
-7,600
-13% -$36K
DRV icon
3383
PUT
Direxion Daily Real Estate Bear 3X ETF
DRV
$25.7M
$247K ﹤0.01%
7,200
-600
-8% -$31.2K
SCHA icon
3384
Schwab U.S Small- Cap ETF
SCHA
$23.1B
$247K ﹤0.01%
+10,476
New +$221K
RVTY icon
3385
Revvity
RVTY
$12.8B
$247K ﹤0.01%
+2,261
New +$218K
ORTX
3386
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$247K ﹤0.01%
+15,000
New +$236K
RXO icon
3387
CALL
RXO
RXO
$3.58B
$247K ﹤0.01%
10,600
-400
-4% -$8.05K
LAC
3388
PUT
Lithium Americas
LAC
$1.17B
$246K ﹤0.01%
+38,500
New +$287K
DUOL icon
3389
Duolingo
DUOL
$6.12B
$246K ﹤0.01%
+1,083
New +$211K
XRX icon
3390
PUT
Xerox
XRX
$425M
$246K ﹤0.01%
+13,400
New +$198K
ARRY icon
3391
CALL
Array Technologies
ARRY
$855M
$245K ﹤0.01%
+14,600
New +$252K
XP icon
3392
PUT
XP
XP
$8.39B
$245K ﹤0.01%
9,400
-12,700
-57% -$290K
HF icon
3393
DGA Absolute Return ETF
HF
$20.9M
$245K ﹤0.01%
+11,840
New +$239K
AUPH icon
3394
PUT
Aurinia Pharmaceuticals
AUPH
$2.11B
$245K ﹤0.01%
27,200
+9,300
+52% +$76.6K
ACHR icon
3395
PUT
Archer Aviation
ACHR
$4.26B
$244K ﹤0.01%
39,700
+6,500
+20% +$36.9K
PSFE icon
3396
PUT
Paysafe
PSFE
$375M
$243K ﹤0.01%
19,036
+6,600
+53% +$72.9K
IYK icon
3397
iShares US Consumer Staples ETF
IYK
$1.41B
$243K ﹤0.01%
+3,807
New +$237K
MUSQ icon
3398
MUSQ Global Music Industry ETF
MUSQ
$21.7M
$243K ﹤0.01%
+9,643
New +$229K
FOLD
3399
PUT
DELISTED
Amicus Therapeutics
FOLD
$243K ﹤0.01%
17,100
-26,600
-61% -$302K
BEN icon
3400
Franklin Resources
BEN
$17.2B
$242K ﹤0.01%
+8,140
New +$203K

Similar funds

GTS Securities's Q4 2023 Portfolio in Review

As of Q4 2023, GTS Securities held 4,579 positions worth $58.7B, up 5.5% from $55.6B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

GTS Securities withdrew a net $4.44B in Q4 2023, closing 585 positions and reducing 1,580 holdings. Its most notable exit was ProShares UltraPro QQQ, an estimated $82.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 1.5% of assets, down from 1.7% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, GTS Securities opened a new position in VanEck Oil Services ETF worth $16.5M.

  • GTS Securities's largest Q4 2023 buy was VanEck Oil Services ETF: 53,223 shares worth $16.5M.
  • GTS Securities added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2023, an estimated $88.4M increase.
  • GTS Securities's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $198M.
  • GTS Securities fully exited ProShares UltraPro QQQ in Q4 2023, selling an estimated $82.8M.
  • GTS Securities's ten largest holdings make up 37% of its $58.7B portfolio in Q4 2023.
  • GTS Securities opened 695 new positions and closed 585 in Q4 2023.
  • GTS Securities's portfolio value rose 5.5% quarter-over-quarter to $58.7B.

Based on GTS Securities's 13F filing for Q4 2023, filed 15 Feb 2024.